Kalqyl publish initial take analysis on Scandinavian ChemoTech
A commissioned research analysis was published today by Kalqyl AB and is accessible on their website."ChemoTech has a clear short-term trigger and inflection point based on the fact that the company recently entered the commercial phase. We see this together with several new collaborations and agreements as strong validation for the potential of ChemoTech's technology platform." writes Peter Westberg, Analyst at Kalqyl AB. The analysis will be disseminated on Kalqyl's Twitter channels and also via Nordnet, Avanza, Di.se, Eikon, Bloomberg and more. See the full analysis on